S3618-119

Reported

No Fentanyl on Social Media Act

119th Congress Introduced Jan 13, 2026

Summary

What This Bill Does

The No Fentanyl on Social Media Act is a reporting bill. It requires the FTC, working with HHS, to study how minors can access fentanyl through social media platforms and report findings to Congress, giving lawmakers a factual basis for future platform, drug-safety, or youth-protection policy.

Who Benefits and How

Minors using social media benefit if the report identifies platform pathways that expose them to fentanyl sales. Parents benefit from federal attention to online fentanyl access risks affecting children. Youth drug prevention programs benefit from evidence about how fentanyl is marketed or accessed online. Congressional consumer protection committees benefit from a formal FTC-HHS report.

Who Bears the Burden and How

FTC must conduct the study and submit the report. HHS must coordinate on drug-risk, youth-health, and prevention information. Social media platforms may face scrutiny over fentanyl access and platform safety practices. Drug dealers using social media face higher enforcement attention if the report identifies platform patterns.

Key Provisions

  • Requires a report on minors' ability to access fentanyl through social media.
  • Directs FTC coordination with HHS.
  • Focuses the report on social media platform access pathways.
  • Provides Congress with evidence for potential future youth online safety legislation.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Requires FTC, in coordination with HHS, to report on minors' ability to access fentanyl through social media platforms.

Key Policy Areas

Technology, Drug Policy, Consumer Protection

Primary Purpose

Requires FTC, in coordination with HHS, to report on minors' ability to access fentanyl through social media platforms.

Policy Domains

Technology Drug Policy Consumer Protection

Bill provisions

Identified Gains
  • Minors using social media
  • Parents
  • Youth drug prevention programs
  • Congressional consumer protection committees
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: is
Parents:
Minors using social media:
Youth drug prevention programs:
Congressional consumer protection committees:
Identified Costs
  • FTC
  • HHS
  • Social media platforms
  • Drug dealers using social media
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: is
FTC:
HHS:
Social media platforms:
Drug dealers using social media:

Legislative Progress

Reported
Introduced Committee Passed
Apr 14, 2026

Committee on Commerce, Science, and Transportation. Ordered to be reported …

Jan 13, 2026

Read twice and referred to the Committee on Commerce, Science, …

Jan 13, 2026

Introduced in Senate

Jan 13, 2026

Mr. Husted (for himself, Ms. Klobuchar, Ms. Blunt Rochester, and …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Government
2 mentions across 1 clause
-2 negative

FTC, HHS

Children
1 mention across 1 clause
+1 positive

Minors using social media

Low-Income Households
1 mention across 1 clause
+1 positive

Parents

General Public
1 mention across 1 clause
+1 positive

Youth drug prevention programs

Technology
1 mention across 1 clause
-1 negative

Social media platforms

1/2
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Technology Drug Policy Consumer Protection
Actor Mappings
"secretary"
→ Secretary of Health and Human Services
"commission"
→ Federal Trade Commission

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology